DOCSLIB.ORG

Comparative Proteomics of Paired Vocal Fold and Oral Mucosa Fibroblasts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Comparative Proteomics of Paired Vocal Fold and Oral Mucosa Fibroblasts Journal of Proteomics 155 (2017) 11–21 Contents lists available at ScienceDirect Journal of Proteomics journal homepage: www.elsevier.com/locate/jprot Comparative proteomics of paired vocal fold and oral mucosa fibroblasts Michael Karbiener a,⁎, Barbara Darnhofer b,c,d, Marie-Therese Frisch e, Beate Rinner e, Ruth Birner-Gruenberger b,c,d, Markus Gugatschka a a Department of Phoniatrics, ENT University Hospital, Medical University of Graz, Austria b Research Unit, Functional Proteomics and Metabolic Pathways, Institute of Pathology, Medical University of Graz, Austria c Omics Center Graz, BioTechMed-Graz, Austria d Austrian Centre of Industrial Biotechnology (ACIB), Austria e Core Facility Alternative Biomodels und Preclinical Imaging, Division of Biomedical Research, Medical University of Graz, Austria article info abstract Article history: Injuries of the vocal folds frequently heal with scar formation, which can have lifelong detrimental impact on Received 31 October 2016 voice quality. Current treatments to prevent or resolve scars of the vocal fold mucosa are highly unsatisfactory. Received in revised form 22 December 2016 In contrast, the adjacent oral mucosa is mostly resistant to scarring. These differences in healing tendency Accepted 12 January 2017 might relate to distinct properties of the fibroblasts populating oral and vocal fold mucosae. We thus established Available online 15 January 2017 the in vitro cultivation of paired, near-primary vocal fold fibroblasts (VFF) and oral mucosa fibroblasts (OMF) to fi Keywords: perform a basic cellular characterization and comparative cellular proteomics. VFF were signi cantly larger than β fi Laryngology OMF, proliferated more slowly, and exhibited a sustained TGF- 1-induced elevation of pro- brotic interleukin 6. Vocal folds Cluster analysis of the proteomic data revealed distinct protein repertoires specific for VFF and OMF. Further, VFF Oral mucosa displayed a broader protein spectrum, particularly a more sophisticated array of factors constituting and modify- Fibroblasts ing the extracellular matrix. Conversely, subsets of OMF-enriched proteins were linked to cellular proliferation, Fibrosis nuclear events, and protection against oxidative stress. Altogether, this study supports the notion that fibroblasts Wound healing sensitively adapt to the functional peculiarities of their respective anatomical location and presents several mo- lecular targets for further investigation in the context of vocal fold wound healing. Biological significance: Mammalian vocal folds are a unique but delicate tissue. A considerable fraction of people is affected by voice problems, yet many of the underlying vocal fold pathologies are sparsely understood at the mo- lecular level. One such pathology is vocal fold scarring - the tendency of vocal fold injuries to heal with scar for- mation -, which represents a clinical problem with highly suboptimal treatment modalities. This study employed proteomics to obtain comprehensive insight into the protein repertoire of vocal fold fibroblasts, which are the cells that predominantly synthesize the extracellular matrix in both physiological and pathophysiological condi- tions. Protein profileswerecomparedtopairedfibroblasts from the oral mucosa, a neighboring tissue that is re- markably resistant to scarring. Bioinformatic analyses of the data revealed a number of pathways as well as single proteins (e.g. ECM-remodeling factors, transcription factors, enzymes) that were significantly different between the two fibroblast types. Thereby, this study has revealed novel interesting molecular targets which can be ana- lyzed in the future for their impact on vocal fold wound healing. © 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/). 1. Introduction structure lead to pathological vibratory behavior and thus are often linked to voice problems, such as hoarseness and an unstable voice Modern society is strongly dependent on successful communication [2]. Indeed, the majority of patients seeking treatment for voice disor- skills, making a healthy voice more important than ever before. Voice ders present with organic vocal fold (VF) changes [3]. Scarring of the production is inextricably linked with physiological vibration of the VF (due to chemical or physical traumata, e.g. surgery of the VF) is one vocal folds, which in turn is enabled by the finely tuned actions of laryn- prominent VF pathology that is characterized by a suboptimal reconsti- geal muscles, as well as by the sophisticated microarchitecture of the tution of the VF lamina propria by its main resident cells, the VF fibro- vocal fold mucosa (VFM) [1]. Detrimental changes of this delicate blasts (VFF) [4]. Presence of a VF scar can be accompanied by a lifelong impairment of voice quality, yet current treatment modalities are largely unsatisfactory. Next-generation medical strategies could ⁎ Corresponding author at: Department of Phoniatrics, ENT University Hospital, Medical University of Graz, Auenbruggerplatz 26, 8036 Graz, Austria. comprise transplantation of ex vivo generated VFM [5,6] or pharmaco- E-mail address: [email protected] (M. Karbiener). logical approaches, i.e. the application of anti-fibrotic drugs [7,8] in http://dx.doi.org/10.1016/j.jprot.2017.01.010 1874-3919/© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 12 M. Karbiener et al. / Journal of Proteomics 155 (2017) 11–21 order to resolve VF scars or even prevent their development. However, adhere by 5–10 min of incubation (without lid). Finally, tissue pieces there is still a marked paucity of knowledge about VFM cells, which were carefully overlaid with serum-reduced growth medium (GM), hampers the development of novel clinical applications. consisting of DMEM/F12 Nutrient Mix (Life Technologies) (3:1), 5% In contrast to the VFM, the oral mucosa (OM) is endowed with a Fetal Bovine Serum (FBS; Biochrom, Berlin, Germany), 1× Insulin- markedly scar-resistant phenotype. Studies that compared healing of Transferrin-Selenium (Life Technologies), 200 nM 3,3′,5-Triiodo-L- oral wounds and scar-prone adult dermis have suggested several factors thyronine, 100 ng/mL human Insulin-like Growth Factor-I, 12.5 ng/mL that contribute to superior healing of the OM [9]. These findings are human Fibroblast growth factor-2 (all Sigma), and 100 μg/mL Normocin largely in agreement with comparisons between adult dermis and (Invivogen, San Diego, CA). Tissue pieces were cultivated in a humidi- fetal dermis, the latter being one of the most intensively studied tissues fied atmosphere at 37 °C and 5% CO2 and GM was partially (50% v/v) re- capable of scarless healing [10,11]. In general, wounds of scar-resistant placed by fresh GM every 2–4 days. After robust outgrowth of tissues were found to contain reduced pro-inflammatory and pro-fi- fibroblastoid cells from adherent tissue pieces (but before the appear- brotic mediators, lower blood vessel density, as well as fast-proliferating ance of a confluent cell layer) the first passaging was performed using epithelial cells and fibroblasts [9,12]. Despite the evident risk of VF inju- 0.5% trypsin (Sigma). Cells were subsequently passaged every 3– ries to heal with scar formation, few of these and other healing-related 4 days at passaging ratios between 1:2 and 1:8. For downstream analy- features have been investigated in the VFM in a comparative manner. ses, seeding of cells into culture plates at defined cell densities was Experiments in rats have identified significant differences in the expres- based on manual counting of trypsinized cell suspensions using a hemo- sion of the cytokines transforming growth factor beta 1 (TGF-β1) and cytometer and subsequent calculation of cell concentrations. transforming growth factor beta 3 (TGF-β3) in VFM versus OM and skin, which likely are related to the distinct healing tendencies of 2.2. Real time cell growth assay these tissues [13]. Further, a recent study has for the first time shed light on global transcriptional changes in the VFM after injury [14]. Cell proliferation was measured using the xCELLigence (OLS OMNI While the classical division of wound healing into the three phases in- Life Science Bremen, Germany) Real-Time Cellular Analysis system. flammation, proliferation, and remodeling might in principle also Briefly, the background impedance was measured following the addi- apply to the VFs, the study's results suggest a considerable overlap of tion of 100 μL of GM to the 16-well E-plates (OLS). Cell suspensions con- the cell division/proliferation and inflammatory activity phases. Further, taining 5000 cells in 100 μLGMwereseededintothewellsand previously undescribed mRNAs with dynamic expression during VF attachment and proliferation were monitored using the xCELLigence wound healing were identified [14], some of which could eventually be- Real-Time Cellular Analysis system. Impedance changes expressed as come therapeutic targets. cell index (CI) were automatically calculated and correlated with cell An alternative way to better define the weak spots of VF wound growth over a period of 100 h. healing is the direct comparison of VF cells to cells arising from tissues with superior healing properties, which is the focus of the present 2.3. 3D spheroid cell culture study. Although VF cells have been benchmarked against other cells with respect to small sets of genes/proteins of interest (e.g. related to 20,000 cells resuspended in GM were seeded in hanging drops the extracellular matrix (ECM) [15] or surface antigens [16,17]), it (20 μL) under the lids (Lactan, Graz, Austria) of cell culture plates. The should be noted that, to date, no comprehensive comparison between dish was carefully inverted to keep the drops intact. 10 mL PBS were a distinct VF cell type and its counterpart in other tissues has been per- added to the bottom of the dish to prevent dehydration. Drops were cul- formed. To close this gap, we first established cell cultures of VFM and tured at 37 °C in 5% CO2 without medium change for up to three days.
Load more

Recommended publications
  • Identification of the RNA Recognition Element of the RBPMS Family of RNA-Binding Proteins and Their Transcriptome-Wide Mrna Targets
    Downloaded from rnajournal.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press Identification of the RNA recognition element of the RBPMS family of RNA-binding proteins and their transcriptome-wide mRNA targets THALIA A. FARAZI,1,5 CARL S. LEONHARDT,1,5 NEELANJAN MUKHERJEE,2 ALEKSANDRA MIHAILOVIC,1 SONG LI,3 KLAAS E.A. MAX,1 CINDY MEYER,1 MASASHI YAMAJI,1 PAVOL CEKAN,1 NICHOLAS C. JACOBS,2 STEFANIE GERSTBERGER,1 CLAUDIA BOGNANNI,1 ERIK LARSSON,4 UWE OHLER,2 and THOMAS TUSCHL1,6 1Laboratory of RNA Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, New York 10065, USA 2Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany 3Biology Department, Duke University, Durham, North Carolina 27708, USA 4Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, SE-405 30, Sweden ABSTRACT Recent studies implicated the RNA-binding protein with multiple splicing (RBPMS) family of proteins in oocyte, retinal ganglion cell, heart, and gastrointestinal smooth muscle development. These RNA-binding proteins contain a single RNA recognition motif (RRM), and their targets and molecular function have not yet been identified. We defined transcriptome-wide RNA targets using photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) in HEK293 cells, revealing exonic mature and intronic pre-mRNA binding sites, in agreement with the nuclear and cytoplasmic localization of the proteins. Computational and biochemical approaches defined the RNA recognition element (RRE) as a tandem CAC trinucleotide motif separated by a variable spacer region. Similar to other mRNA-binding proteins, RBPMS family of proteins relocalized to cytoplasmic stress granules under oxidative stress conditions suggestive of a support function for mRNA localization in large and/or multinucleated cells where it is preferentially expressed.
    [Show full text]
  • Supplementary Methods
    Supplementary methods Human lung tissues and tissue microarray (TMA) All human tissues were obtained from the Lung Cancer Specialized Program of Research Excellence (SPORE) Tissue Bank at the M.D. Anderson Cancer Center (Houston, TX). A collection of 26 lung adenocarcinomas and 24 non-tumoral paired tissues were snap-frozen and preserved in liquid nitrogen for total RNA extraction. For each tissue sample, the percentage of malignant tissue was calculated and the cellular composition of specimens was determined by histological examination (I.I.W.) following Hematoxylin-Eosin (H&E) staining. All malignant samples retained contained more than 50% tumor cells. Specimens resected from NSCLC stages I-IV patients who had no prior chemotherapy or radiotherapy were used for TMA analysis by immunohistochemistry. Patients who had smoked at least 100 cigarettes in their lifetime were defined as smokers. Samples were fixed in formalin, embedded in paraffin, stained with H&E, and reviewed by an experienced pathologist (I.I.W.). The 413 tissue specimens collected from 283 patients included 62 normal bronchial epithelia, 61 bronchial hyperplasias (Hyp), 15 squamous metaplasias (SqM), 9 squamous dysplasias (Dys), 26 carcinomas in situ (CIS), as well as 98 squamous cell carcinomas (SCC) and 141 adenocarcinomas. Normal bronchial epithelia, hyperplasia, squamous metaplasia, dysplasia, CIS, and SCC were considered to represent different steps in the development of SCCs. All tumors and lesions were classified according to the World Health Organization (WHO) 2004 criteria. The TMAs were prepared with a manual tissue arrayer (Advanced Tissue Arrayer ATA100, Chemicon International, Temecula, CA) using 1-mm-diameter cores in triplicate for tumors and 1.5 to 2-mm cores for normal epithelial and premalignant lesions.
    [Show full text]
  • Figure S1. Androgen Signaling Upregulates an Intronic
    Figure S1. Androgen signaling upregulates an intronic polyadenylated EWSR1 isoform A) Gene expression correlation of EWSR1 and AR in 550 prostate cancer patients from the PRAD data set. B) EWSR1 polyadenylation site (PAS) information from PolyA_db v3.2. There are seven PAS for this gene and they are numbered starting from the 5’ end of the gene. C) Diagram of PAS locations at EWSR1 numbered according to table in A. D) Normalized read count for PAS #2, the PAS for ntEWS, from 3’ sequencing data across various cell types. E) RNA levels of PSA in VCaP, LNCaP, and LNCaP-AR cells treated with DMSO or 10nM R1881 for 24 hours. Expression is normalized to 18S and relative to the DMSO condition. The mean ± SEM for three replicates is shown. F) Immuno blot of ntEWS in PC3 cells overexpressing HA-ntEWS. G) Immunoblot of ntEWS in VCaP cells overexpressing vector alone or shRNAs targeting the 3’ UTR of ntEWS. Tubulin is used as a loading control for immunoblots. Figure S2. AR binding to Intron 5 of EWSR1 directly regulates ntEWS expression A) Gene tracks for AR binding in patient tumor and matched adjacent normal tissue at known AR enhancers. Order of tracks is consistent with Figure 2a. Figure S3. ntEWS promotes phenotypes related to oncogenesis A) Immunoblot of 3xHA tagged EWS isoforms expressed in PC3 cells. Tubulin is used as a loading control. B) MTT proliferation assay of PC3 isoform-expressing lines. Figure S4. The ntEWS alternative last exon encodes an alpha helical domain important for function A) IUPRED prediction of disorder of ntEWS (bottom) and EWS(1-355aa) (top).
    [Show full text]
  • Proteomics Analysis of Cellular Proteins Co-Immunoprecipitated with Nucleoprotein of Influenza a Virus (H7N9)
    Article Proteomics Analysis of Cellular Proteins Co-Immunoprecipitated with Nucleoprotein of Influenza A Virus (H7N9) Ningning Sun 1,:, Wanchun Sun 2,:, Shuiming Li 3, Jingbo Yang 1, Longfei Yang 1, Guihua Quan 1, Xiang Gao 1, Zijian Wang 1, Xin Cheng 1, Zehui Li 1, Qisheng Peng 2,* and Ning Liu 1,* Received: 26 August 2015 ; Accepted: 22 October 2015 ; Published: 30 October 2015 Academic Editor: David Sheehan 1 Central Laboratory, Jilin University Second Hospital, Changchun 130041, China; [email protected] (N.S.); [email protected] (J.Y.); [email protected] (L.Y.); [email protected] (G.Q.); [email protected] (X.G.); [email protected] (Z.W.); [email protected] (X.C.); [email protected] (Z.L.) 2 Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, Jilin University, Changchun 130062, China; [email protected] 3 College of Life Sciences, Shenzhen University, Shenzhen 518057, China; [email protected] * Correspondence: [email protected] (Q.P.); [email protected] (N.L.); Tel./Fax: +86-431-8879-6510 (Q.P. & N.L.) : These authors contributed equally to this work. Abstract: Avian influenza A viruses are serious veterinary pathogens that normally circulate among avian populations, causing substantial economic impacts. Some strains of avian influenza A viruses, such as H5N1, H9N2, and recently reported H7N9, have been occasionally found to adapt to humans from other species. In order to replicate efficiently in the new host, influenza viruses have to interact with a variety of host factors. In the present study, H7N9 nucleoprotein was transfected into human HEK293T cells, followed by immunoprecipitated and analyzed by proteomics approaches.
    [Show full text]
  • Large-Scale Analysis of Genome and Transcriptome Alterations in Multiple Tumors Unveils Novel Cancer-Relevant Splicing Networks
    Downloaded from genome.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks Endre Sebestyén1,*, Babita Singh1,*, Belén Miñana1,2, Amadís Pagès1, Francesca Mateo3, Miguel Angel Pujana3, Juan Valcárcel1,2,4, Eduardo Eyras1,4,5 1Universitat Pompeu Fabra, Dr. Aiguader 88, E08003 Barcelona, Spain 2Centre for Genomic Regulation, Dr. Aiguader 88, E08003 Barcelona, Spain 3Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), E08908 L’Hospitalet del Llobregat, Spain. 4Catalan Institution for Research and Advanced Studies, Passeig Lluís Companys 23, E08010 Barcelona, Spain *Equal contribution 5Correspondence to: [email protected] Keywords: alternative splicing, RNA binding proteins, splicing networks, cancer 1 Downloaded from genome.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract Alternative splicing is regulated by multiple RNA-binding proteins and influences the expression of most eukaryotic genes. However, the role of this process in human disease, and particularly in cancer, is only starting to be unveiled. We systematically analyzed mutation, copy number and gene expression patterns of 1348 RNA-binding protein (RBP) genes in 11 solid tumor types, together with alternative splicing changes in these tumors and the enrichment of binding motifs in the alternatively spliced sequences. Our comprehensive study reveals widespread alterations in the expression of RBP genes, as well as novel mutations and copy number variations in association with multiple alternative splicing changes in cancer drivers and oncogenic pathways. Remarkably, the altered splicing patterns in several tumor types recapitulate those of undifferentiated cells.
    [Show full text]
  • Identification of Proteins Involved in the Maintenance of Genome Stability
    Identification of Proteins Involved in the Maintenance of Genome Stability by Edith Hang Yu Cheng A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Biochemistry University of Toronto ©Copyright by Edith Cheng2015 Identification of Proteins Involved in the Maintenance of Genome Stability Edith Cheng Doctor of Philosophy Department of Biochemistry University of Toronto 2015 Abstract Aberrant changes to the genome structure underlie numerous human diseases such as cancers. The functional characterization ofgenesand proteins that maintain chromosome stability will be important in understanding disease etiology and developing therapeutics. I took a multi-faceted approach to identify and characterize genes involved in the maintenance of genome stability. As biological pathways involved in genome maintenance are highly conserved in evolution, results from model organisms can greatly facilitate functional discovery in humans. In S. cerevisiae, I identified 47 essential gene depletions with elevated levels of spontaneous DNA damage foci and 92 depletions that caused elevated levels of chromosome rearrangements. Of these, a core subset of 15 DNA replication genes demonstrated both phenotypes when depleted. Analysis of rearrangement breakpoints revealed enrichment at yeast fragile sites, Ty retrotransposons, early origins of replication and replication termination sites. Together, thishighlighted the integral role of DNA replicationin genome maintenance. In light of my findings in S. cerevisiae, I identified a list of 153 human proteins that interact with the nascentDNA at replication forks, using a DNA pull down strategy (iPOND) in human cell lines. As a complementary approach for identifying human proteins involved in genome ii maintenance, I usedthe BioID techniqueto discernin vivo proteins proximal to the human BLM- TOP3A-RMI1-RMI2 genome stability complex, which has an emerging role in DNA replication progression.
    [Show full text]
  • Roles of Splicing Factors in Hormone-Related Cancer Progression
    International Journal of Molecular Sciences Review Roles of Splicing Factors in Hormone-Related Cancer Progression Toshihiko Takeiwa 1, Yuichi Mitobe 1, Kazuhiro Ikeda 1, Kuniko Horie-Inoue 1 and Satoshi Inoue 1,2,* 1 Division of Gene Regulation and Signal Transduction, Research Center for Genomic Medicine, Saitama Medical University, Hidaka, Saitama 350-1241, Japan; [email protected] (T.T.); [email protected] (Y.M.); [email protected] (K.I.); [email protected] (K.H.-I.) 2 Department of Systems Aging Science and Medicine, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Tokyo 173-0015, Japan * Correspondence: [email protected]; Tel.: +81-3-3964-3241 Received: 8 February 2020; Accepted: 20 February 2020; Published: 25 February 2020 Abstract: Splicing of mRNA precursor (pre-mRNA) is a mechanism to generate multiple mRNA isoforms from a single pre-mRNA, and it plays an essential role in a variety of biological phenomena and diseases such as cancers. Previous studies have demonstrated that cancer-specific splicing events are involved in various aspects of cancers such as proliferation, migration and response to hormones, suggesting that splicing-targeting therapy can be promising as a new strategy for cancer treatment. In this review, we focus on the splicing regulation by RNA-binding proteins including Drosophila behavior/human splicing (DBHS) family proteins, serine/arginine-rich (SR) proteins and heterogeneous nuclear ribonucleoproteins (hnRNPs) in hormone-related cancers, such as breast and prostate cancers. Keywords: DBHS family proteins; SR proteins; hnRNPs; breast cancer; prostate cancer 1. Introduction Splicing of mRNA precursors (pre-mRNAs) is an essential mechanism in the posttranscriptional regulation of gene expression.
    [Show full text]
  • The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants And
    Author Manuscript Published OnlineFirst on July 16, 2018; DOI: 10.1158/1078-0432.CCR-17-3850 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle invasive bladder cancer Pamela Bielli1,2, Valentina Panzeri2,3,4, Rossano Lattanzio5,6, Simona Mutascio1,2, Marco Pieraccioli1,2, Elisabetta Volpe2, Vincenzo Pagliarulo7, Mauro Piantelli5, Antonella Giannantoni8; Savino M. Di Stasi9,10 and Claudio Sette2,4,10 1Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy; 2Fondazione Santa Lucia IRCCS, Rome, Italy; 3Department of science medical/chirurgic and translational medicine, University of Rome “Sapienza”, Rome, Italy; 4Institute of Human Anatomy and Cell Biology, Università Cattolica del Sacro Cuore, Rome, Italy; 5Department of Medical, Oral & Biotechnological Sciences, G. d'Annunzio University, Chieti, Italy; 6 Center of Excellence on Aging and Translational Medicine (CeSi-Met), G. d'Annunzio University, Chieti, Italy; 7Department of Emergency and Organ Transplantation, University Aldo Moro , Bari, Italy; 8Department of Surgical and Biomedical Sciences, University of Perugia, Perugia, Italy; 9Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy. 10These authors equally contributed to the work. Running title: PTBP1 is overexpressed in bladder cancer Keywords: PTBP1, alternative splicing, bladder cancer, risk factor, prognostic marker Conflict of interest statement: The Authors have no conflicts of interest to disclose. Financial Support: The research was supported by the Associazione Italiana Ricerca sul Cancro (AIRC; IG18790) and by Italian Ministry of Health “Ricerca Finalizzata 2011” (GR- 2011-02348423).
    [Show full text]
  • The Splicing Regulator PTBP1 Controls the Activity of the Transcription Factor
    1 The splicing regulator PTBP1 controls the activity of the 2 transcription factor Pbx1 during neuronal differentiation. 3 4 Anthony J Linares1, Chia-Ho Lin2, Andrey Damianov2, Katrina L Adams1,3,4, Bennett G 5 Novitch3,4, Douglas L Black2,4 6 1Molecular Biology Institute Graduate Program, University of California, Los Angeles; 2Department of 7 Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles; 3Department of 8 Neurobiology, David Geffen School of Medicine at UCLA; 4Eli and Edythe Broad Center of Regenerative 9 Medicine and Stem Cell Research, David Geffen School of Medicine at UCLA, Los Angeles, United States. 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 1 27 ABSTRACT 28 29 The RNA-binding proteins PTBP1 and PTBP2 control programs of alternative splicing 30 during neuronal development. PTBP2 was found to maintain embryonic splicing patterns 31 of many synaptic and cytoskeletal proteins during differentiation of neuronal progenitor 32 cells (NPCs) into early neurons. However, the role of the earlier PTBP1 program in 33 embryonic stem cells (ESCs) and NPCs was not clear. We show that PTBP1 controls a 34 program of neuronal gene expression that includes the transcription factor Pbx1. We 35 identify exons specifically regulated by PTBP1 and not PTBP2 as mouse ESCs 36 differentiate into NPCs. We find that PTBP1 represses Pbx1 exon 7 and the expression 37 of the neuronal Pbx1a isoform in ESCs. Using CRISPR-Cas9 to delete regulatory 38 elements for exon 7, we induce Pbx1a expression in ESCs, finding that this activates 39 transcription of neuronal genes.
    [Show full text]
  • Significance of Polypyrimidine Tract–Binding Protein 1 Expression In
    Published OnlineFirst April 22, 2015; DOI: 10.1158/1535-7163.MCT-14-0142 Cancer Biology and Signal Transduction Molecular Cancer Therapeutics Significance of Polypyrimidine Tract–Binding Protein 1 Expression in Colorectal Cancer Hidekazu Takahashi1, Junichi Nishimura1, Yoshinori Kagawa1,2, Yoshihiro Kano3, Yusuke Takahashi1,4, Xin Wu1, Masayuki Hiraki1, Atsushi Hamabe1, Masamitsu Konno3, Naotsugu Haraguchi1, Ichiro Takemasa1, Tsunekazu Mizushima1, Masaru Ishii2, Koshi Mimori4, Hideshi Ishii3, Yuichiro Doki1, Masaki Mori1, and Hirofumi Yamamoto1 Abstract Polypyrimidine tract–binding protein (PTBP1) is an RNA- observed that PTBP1 affects cell invasion, which was partially binding protein with various molecular functions related to correlated to CD44 splicing, and this correlation was also RNA metabolism and a major repressive regulator of alternative confirmed in clinical samples. PTBP1 expression also affected splicing, causing exon skipping in numerous alternatively anchorage-independent growth in colorectal cancer cell lines. spliced pre-mRNAs. Here, we have investigated the role of PTBP1 expression also affected cell proliferation. Using time- PTBP1 in colorectal cancer. PTBP1 expression levels were sig- lapse imaging analysis, PTBP1 was implicated in prolonged nificantly overexpressed in cancerous tissues compared with G2–M phase in HCT116 cells. As for the mechanism of pro- corresponding normal mucosal tissues. We also observed that longed G2–M phase in HCT116 siPTBP1 cells, Western blotting PTBP1 expression levels, c-MYC expression levels, and PKM2: revealed that PTBP1 expression level was correlated to PKM1 ratio were positively correlated in colorectal cancer CDK11p58 expression level, which was reported to play an specimens. Moreover, PTBP1 expression levels were positively important role on progression to complete mitosis. These correlated to poor prognosis and lymph node metastasis.
    [Show full text]
  • Regulation of Alternative Splicing by the Core Spliceosomal Machinery
    Downloaded from genesdev.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press Regulation of alternative splicing by the core spliceosomal machinery Arneet L. Saltzman,1,2 Qun Pan,1 and Benjamin J. Blencowe1,2,3 1Banting and Best Department of Medical Research, The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada; 2Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada Alternative splicing (AS) plays a major role in the generation of proteomic diversity and in gene regulation. However, the role of the basal splicing machinery in regulating AS remains poorly understood. Here we show that the core snRNP (small nuclear ribonucleoprotein) protein SmB/B9 self-regulates its expression by promoting the inclusion of a highly conserved alternative exon in its own pre-mRNA that targets the spliced transcript for nonsense-mediated mRNA decay (NMD). Depletion of SmB/B9 in human cells results in reduced levels of snRNPs and a striking reduction in the inclusion levels of hundreds of additional alternative exons, with comparatively few effects on constitutive exon splicing levels. The affected alternative exons are enriched in genes encoding RNA processing and other RNA-binding factors, and a subset of these exons also regulate gene expression by activating NMD. Our results thus demonstrate a role for the core spliceosomal machinery in controlling an exon network that appears to modulate the levels of many RNA processing factors. [Keywords: alternative splicing; Sm proteins; snRNP; autoregulation; NMD; exon network] Supplemental material is available for this article. Received October 20, 2010; revised version accepted January 4, 2011.
    [Show full text]
  • Disruption of Nucleocytoplasmic Trafficking As a Cellular Senescence
    www.nature.com/emm ARTICLE OPEN Disruption of nucleocytoplasmic trafficking as a cellular senescence driver Ji-Hwan Park1,14, Sung Jin Ryu2,13,14, Byung Ju Kim3,13,14, Hyun-Ji Cho3, Chi Hyun Park4, Hyo Jei Claudia Choi2, Eun-Jin Jang3, Eun Jae Yang5, Jeong-A Hwang5, Seung-Hwa Woo5, Jun Hyung Lee5, Ji Hwan Park5, Kyung-Mi Choi6, Young-Yon Kwon6, 6 7 3 3 8 9 10 5 ✉ Cheol-Koo Lee , Joon✉ Tae Park , Sung✉ Chun Cho , Yun-Il Lee , Sung✉ Bae Lee , Jeong A. Han , Kyung A. Cho , Min-Sik Kim , Daehee Hwang11 , Young-Sam Lee3,5 and Sang Chul Park3,12 © The Author(s) 2021 Senescent cells exhibit a reduced response to intrinsic and extrinsic stimuli. This diminished reaction may be explained by the disrupted transmission of nuclear signals. However, this hypothesis requires more evidence before it can be accepted as a mechanism of cellular senescence. A proteomic analysis of the cytoplasmic and nuclear fractions obtained from young and senescent cells revealed disruption of nucleocytoplasmic trafficking (NCT) as an essential feature of replicative senescence (RS) at the global level. Blocking NCT either chemically or genetically induced the acquisition of an RS-like senescence phenotype, named nuclear barrier-induced senescence (NBIS). A transcriptome analysis revealed that, among various types of cellular senescence, NBIS exhibited a gene expression pattern most similar to that of RS. Core proteomic and transcriptomic patterns common to both RS and NBIS included upregulation of the endocytosis-lysosome network and downregulation of NCT in senescent cells, patterns also observed in an aging yeast model.
    [Show full text]